Ghost Tree Capital, LLC Pmv Pharmaceuticals, Inc. Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.51 - $2.21 $453,000 - $663,000	-300,000 Reduced 44.44%	375,000 $607,000
Q1 2024 May 15, 2024	SELL	$1.51 - $3.12 $75,500 - $156,000	-50,000 Reduced 6.9%	675,000 $1.15 Million
Q4 2023 Feb 14, 2024	BUY	$1.23 - $6.6 $23,516 - $126,185	19,119 Added 2.71%	725,000 $2.25 Million
Q3 2023 Nov 14, 2023	BUY	$6.01 - $8.93 $2.55 Million - $3.79 Million	424,900 Added 151.22%	705,881 $4.33 Million
Q2 2023 Aug 14, 2023	BUY	$3.94 - $6.27 $1.11 Million - $1.76 Million	280,981 New	280,981 $1.76 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.